STAT3 and lung adenocarcinoma: In both the GSE41271 and TCGA lung adenocarcinoma cohorts, the IL6-JAK-STAT3 pathway was activated in the MDSC high infiltration group, while the IL6-JAK-STAT3 pathway was inhibited in the IRF8 high-expression group (Fig. 6A, B).